Jane L. Liesveld

BCL-2 Inhibition Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cells

Eleni D. Lagadinou, Alexander Sach, Kevin P. Callahan et al. · Cell stem cell · 2013 · 1.4K citations · Full text

Life Sciences, Cell Biology, Oncology +12

Long-Lived Plasma Cells Are Contained within the CD19−CD38hiCD138+ Subset in Human Bone Marrow

Jessica L. Halliley, Christopher M. Tipton, Jane L. Liesveld et al. · Immunity · 2015 · 542 citations · Full text

Medicine, Hematology, Immunology +13

Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial

Judith E. Karp, Jeffrey E. Lancet, Scott H. Kaufmann et al. · Blood · 2001 · 445 citations · Full text

Medicine, Oncology, Pharmacology +9

Rapid Mobilization of CD34+ Cells Following Administration of the CXCR4 Antagonist AMD3100 to Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma

Steven M. Devine, Neal Flomenberg, David H. Vesole et al. · Journal of Clinical Oncology · 2004 · 416 citations · Full text

Medicine, Hematology, Pharmacology +15

An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells

Mónica L. Guzmán, Randall M. Rossi, Sundar Neelakantan et al. · Blood · 2007 · 410 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14